@dannykpolitics.bsky.socialNEW: PhRMA files suit challenging Trump Medicare most favored nation drug pricing rule
PhRMA alleges CMS GLOBE Part B rebates illegally import foreign price controls; seeks vacatur in D.C. court.
🟣🗞️ #PhRMA #Medicare #GLOBE #Trump #DrugPricing
@thepharmacistnews.bsky.socialDrug price concessions hit new record high
#priceconcessions #drugpricing #pharmacy #medicines #drugtariff
@gmj-georgia.bsky.socialMedicare has proposed fresh cuts to the 340B drug discount program that serves safety-net hospitals. The move marks another regulatory attempt to address cost… #340B #Drugpricing #Healthcarepolicy #Hospitalreimbursement #Medicare #340B #Drugpricing #Healthcarepolicy #Hospitalreimbursement #Medi…
@thepharmacistnews.bsky.socialDrug price concessions hit new record high
#priceconcessions #drugpricing #pharmacy #medicines #drugtariff
@resist47.newsMedicare finalized a new payment model, aiming to lower drug prices in doctors' offices to match international rates.
resist47.news — up-to-date resistance news.
#resist47 #Medicare #DrugPricing #TrumpAdministration #HealthcarePolicy
@pharmaphorum.bsky.socialThe Centers for Medicare and Medicaid Services (#CMS) has finalised a new #drugpricing #policy for #Medicare that has drawn sharp criticism from the #pharma industry.
@4040rec.bsky.social
@killbaitcanada.bsky.socialTrump's 'most favoured nation' drug pricing policy could increase Canadian drug costs, experts warn
🤖 IA: It's not clickbait ✅
đź‘Ą Users: It's not clickbait âś…
#drugpricing #pharmaceuticals #trump
👇👇👇
@newsmason.bsky.social#trends today for 'russia sanctions' 'drug pricing' & 'dolly parton'
Click/Tap below:
www.newsmason.com?query=%22rus...
www.newsmason.com?query=%22dru...
@agentictribune.bsky.socialWhite House Projects $64.3B in Medicaid Drug Savings Under Voluntary GENEROUS Model, But Manufacturer Deals Remain Secret
@resist47.newsPresident Trump will announce that all 50 states will secure "most favored nation" drug pricing under Medicaid, aimed at lowering costs for voters.
resist47.news — up-to-date resistance news.
#resist47 #Medicaid #DrugPricing #WhiteHouse #HealthcarePolicy
@icer-review.bsky.socialToday's Weekly View includes ICER President and CEO Sarah Emond's perspective on the apitegromab approval (now branded Isembyld). Read here: conta.cc/4y2W6dF
#isembyld #DrugPricing #PharmaPricing #ValueBasedPricing #MarketAccess #Healthcare
@gmj-georgia.bsky.socialUS lawmakers have called on HHS to enforce Eli Lilly's participation in the 340B drug discount program, which provides discounted medications… #340Bprogram #Drugpricing #Hospitalaccess #Patientadvocacy #Pharmaceuticalcompliance #340Bprogram #Drugpricing #Hospitalaccess #Patientadvocacy #Pharmac…
@ipharmaservices.bsky.socialO #InflationReductionAct muda preços de #Medicare. O #CMS já negocia direto com a indústria; primeiros preços valem desde 2026: www.ipharmacenter.com/post/us-infl... #IRA #DrugPricing #Pharma #pharmaceutical #healthcare
@ipharmaservices.bsky.socialDer #InflationReductionAct ändert #Medicare-Preise. #CMS verhandelt direkt mit Herstellern; erste Preise traten 2026 in Kraft: www.ipharmacenter.com/post/us-infl... #IRA #DrugPricing #BidenAdministration #Pharma #pharmaceutical #healthcare
@ipharmaservices.bsky.socialL'#InflationReductionAct redéfinit les prix #Medicare. Le #CMS négocie en direct avec l'industrie; premiers prix entrés en vigueur en 2026: www.ipharmacenter.com/post/us-infl... #IRA #DrugPricing #Pharma #pharmaceutical #healthcare
@ipharmaservices.bsky.socialLa #InflationReductionAct cambia precios de #Medicare. #CMS ya negocia directo con farmacéuticas; primeros precios entraron en vigor en 2026: www.ipharmacenter.com/post/us-infl...
#IRA #DrugPricing #Pharma #pharmaceutical #healthcare
@ipharmaservices.bsky.socialThe #InflationReductionAct is reshaping #Medicare drug pricing. #CMS can now negotiate drug prices directly with pharma. First negotiated prices took effect in 2026.
www.ipharmacenter.com/post/us-infl...
#IRA #DrugPricing #BidenAdministration #Pharma #pharmaceutical #healthcare
@4040rec.bsky.social
@oddlytruejp.bsky.socialđź’Š Japan keeps drug prices low by design. That has now become an American export.
Astellas and Kyowa Kirin signed most-favored-nation deals with Washington — the first Japanese drugmakers to do so. US prices get benchmarked against Japan's.